Baxter International (BAX) Earnings Analysis
Baxter International (BAX) next reports earnings on 2026-07-30, consensus EPS 0.36 USD. Last quarter (2026-04-30) it beat with EPS 0.36 USD vs 0.311 USD est (+15.8%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -10.35.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BAX next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.36 USD |
| Revenue estimate | 2.79B |
BAX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.36 USD | 0.311 USD | +15.8% | Beat |
| 2026-02-12 | 0.44 USD | 0.53 USD | -17% | Miss |
| 2025-10-30 | 0.69 USD | 0.6 USD | +15% | Beat |
| 2025-07-31 | 0.59 USD | 0.6 USD | -1.7% | Miss |
| 2025-05-01 | 0.55 USD | 0.4835 USD | +13.8% | Beat |
| 2025-02-20 | 0.58 USD | 0.528 USD | +9.8% | Beat |
| 2024-11-08 | 0.8 USD | 0.78 USD | +2.6% | Beat |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
BAX valuation and analyst view
| Trailing P/E | -10.35 |
|---|---|
| Trailing EPS | -2.13204 USD |
| Price / book | 1.85 |
| Dividend yield | 0.92% |
| Market cap | 11.40B |
| Analyst consensus | Hold (15 buy / 19 hold / 2 sell) |
| Avg price target | 24 USD |
Related research pages
Frequently asked questions
When is Baxter International (BAX)'s next earnings date?
Baxter International is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.36 USD and revenue estimate of 2.79B.
Did BAX beat earnings last quarter?
In its 2026-04-30 report, BAX posted EPS of 0.36 USD versus a 0.311 USD estimate — a beat of 15.8%.
What is BAX's earnings track record?
Over the last 7 reported quarters with consensus data, BAX beat estimates 5 times (71%).
What is BAX's current P/E ratio and EPS?
BAX trades at a trailing P/E of -10.35 on trailing EPS of -2.1320388349514565 USD.
What do analysts rate BAX?
Analyst consensus is "Hold" across 36 ratings (0 strong buy, 15 buy, 19 hold, 2 sell, 0 strong sell). Average 12-month price target: 24 USD.